{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:18:16Z","timestamp":1773368296029,"version":"3.50.1"},"reference-count":316,"publisher":"American Chemical Society (ACS)","issue":"16","funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["IF\/00442\/2012"],"award-info":[{"award-number":["IF\/00442\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/QEQ-PRS\/2757\/2012"],"award-info":[{"award-number":["PTDC\/QEQ-PRS\/2757\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/73560\/2010"],"award-info":[{"award-number":["SFRH\/BD\/73560\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Rev."],"published-print":{"date-parts":[[2015,8,26]]},"DOI":"10.1021\/cr300095f","type":"journal-article","created":{"date-parts":[[2015,8,7]],"date-time":"2015-08-07T19:26:54Z","timestamp":1438975614000},"page":"8182-8229","source":"Crossref","is-referenced-by-count":173,"title":["Genotoxic Impurities in Pharmaceutical Manufacturing: Sources, Regulations, and Mitigation"],"prefix":"10.1021","volume":"115","author":[{"given":"Gyorgy","family":"Szekely","sequence":"first","affiliation":[{"name":"School of Chemical Engineering & Analytical Science, The University of Manchester, The Mill, Sackville Street, Manchester M13 9PL, United Kingdom"}]},{"given":"Miriam C.","family":"Amores de Sousa","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Institute for Bioengineering and Biosciences (iBB), Instituto Superior T\u00e9cnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal"}]},{"given":"Marco","family":"Gil","sequence":"additional","affiliation":[{"name":"Hovione FarmaCiencia SA, R&D, Sete Casas, 2674-506, Loures, Portugal"}]},{"given":"Frederico","family":"Castelo Ferreira","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Institute for Bioengineering and Biosciences (iBB), Instituto Superior T\u00e9cnico, Universidade de Lisboa, Avenida Rovisco Pais, 1049-001, Lisbon, Portugal"}]},{"given":"William","family":"Heggie","sequence":"additional","affiliation":[{"name":"Hovione FarmaCiencia SA, R&D, Sete Casas, 2674-506, Loures, Portugal"}]}],"member":"316","published-online":{"date-parts":[[2015,8,7]]},"reference":[{"key":"ref1\/cit1","unstructured":"Web of Science.http:\/\/thomsonreuters.com\/products_services\/science\/science_products\/a-z\/web_of_science\/, accessed April 27, 2012."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1021\/op8002129"},{"key":"ref3\/cit3","volume-title":"Questions and Answers on the \u2018Guideline on the Limits of Genotoxic Impurities\u2019","author":"Committee for Medicinal Products for Human Use (CHMP), Safety Working Party (SWP)","year":"2010"},{"key":"ref4\/cit4","first-page":"605","volume-title":"Origin of Human Cancers","author":"Miller J. A.","year":"1977"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1093\/mutage\/geh043"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2014.12.012"},{"key":"ref7\/cit7","volume-title":"Report EUR 24640 EN","author":"Worth A."},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1002\/em.20013"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03505-1"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1021\/op100007q"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/op200205b"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1021\/op900341a"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2006.10.007"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1021\/cr100222q"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1080\/15287398009529934"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(98)01146-6"},{"key":"ref17\/cit17","volume-title":"Genotoxic Impurities\u2014Strategies for Identification and Control","author":"Teasdale A.","year":"2010"},{"key":"ref18\/cit18","unstructured":"Pullman, A.; Ts\u2019o, P. O. P.; Gelboin, H. V.Carcinogenesis: Fundamental Mechanisms and Environmental Effects;D. Reidel Publishing Co.:Dordrecht, Netherlands, 1980; p55."},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1002\/em.20062"},{"key":"ref20\/cit20","first-page":"517","volume-title":"Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification","author":"Woo Y. T.","year":"2010"},{"key":"ref21\/cit21","first-page":"27","volume":"12","author":"European Directorate for the Quality of Medicines and Healthcare.","year":"2000","journal-title":"PharmEuropa"},{"key":"ref22\/cit22","volume-title":"Guidelines on the Limits of Genotoxic Impurities","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2004"},{"key":"ref23\/cit23","first-page":"6","volume":"19","author":"Elder D.","year":"2014","journal-title":"Eur. Pharm. Rev."},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfi169"},{"key":"ref25\/cit25","unstructured":"Huntingdon Life Sciences.http:\/\/landing.huntingdon.com\/the-threshold-of-toxicological-concern-concept-and-its-usein-agrochemical-and-chemical-regulation\/, accessed Jan 15, 2015."},{"key":"ref26\/cit26","unstructured":"Snodin, D. J.; Elder, D. P.Genotoxic Impurities Part 1: General Overview.Pharm. OutsourcingMay 25, 2012, (http:\/\/www.pharmoutsourcing.com\/Featured-Articles\/113769-Genotoxic-Impurities-Part-1-General-Overview\/)."},{"key":"ref27\/cit27","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/kfm173"},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2005.12.001"},{"key":"ref29\/cit29","volume-title":"Scientific Article 5(3) Opinion on: The Potential Risks of Carcinogens, Mutagens and Substances Toxic to Reproduction when these Substances are used as Excipients of Medicinal Products for Human Use","author":"Committee for Human Medicinal Products (CHMP)","year":"2008"},{"key":"ref30\/cit30","volume-title":"Guidelines on The Limits of Genotoxic Impurities","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2006"},{"key":"ref31\/cit31","volume-title":"Guidance for Industry. Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches","year":"2008"},{"key":"ref32\/cit32","volume-title":"ICH Guideline M7 on Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals To Limit Potential Carcinogenic Risk","author":"EMEA","year":"2014"},{"key":"ref33\/cit33","doi-asserted-by":"publisher","DOI":"10.1021\/op500061a"},{"key":"ref34\/cit34","doi-asserted-by":"publisher","DOI":"10.1021\/op1001337"},{"key":"ref35\/cit35","doi-asserted-by":"publisher","DOI":"10.1021\/op300194c"},{"key":"ref36\/cit36","doi-asserted-by":"publisher","DOI":"10.1021\/jm049029u"},{"key":"ref37\/cit37","doi-asserted-by":"publisher","DOI":"10.1021\/ja9726015"},{"key":"ref38\/cit38","doi-asserted-by":"publisher","DOI":"10.1021\/op3000459"},{"key":"ref39\/cit39","doi-asserted-by":"publisher","DOI":"10.1021\/op300268u"},{"key":"ref40\/cit40","doi-asserted-by":"publisher","DOI":"10.1021\/op100072y"},{"key":"ref41\/cit41","doi-asserted-by":"publisher","DOI":"10.1021\/op400139z"},{"key":"ref42\/cit42","doi-asserted-by":"publisher","DOI":"10.1021\/op1000989"},{"key":"ref43\/cit43","doi-asserted-by":"publisher","DOI":"10.1021\/op300212u"},{"key":"ref44\/cit44","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2007.06.008"},{"key":"ref45\/cit45","doi-asserted-by":"publisher","DOI":"10.3109\/10408449309105011"},{"key":"ref46\/cit46","doi-asserted-by":"publisher","DOI":"10.5483\/BMBRep.2003.36.1.020"},{"key":"ref47\/cit47","doi-asserted-by":"publisher","DOI":"10.1021\/cr9800199"},{"key":"ref48\/cit48","doi-asserted-by":"publisher","DOI":"10.1021\/op9000737"},{"key":"ref49\/cit49","doi-asserted-by":"publisher","DOI":"10.1080\/00397919608004796"},{"key":"ref50\/cit50","unstructured":"Edwards, P. N.; Large, M. S.(Substituted Aralkyl) Heterocyclic Compounds. U.S. Patent 4,935,437, June 19, 1990."},{"key":"ref51\/cit51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2007.04.004"},{"key":"ref52\/cit52","doi-asserted-by":"publisher","DOI":"10.1002\/hlca.200390235"},{"key":"ref53\/cit53","unstructured":"Kennis, L. E. J.; Vandenberk, J.3-Piperidinyl-Substituted 1,2-Benzisoxazoles and 1,2-Benzisothiazoles. U.S. Patent 4,804,663, February 14, 1989."},{"key":"ref54\/cit54","unstructured":"Yu, C. N.; Pelosi, S. S.; Calcagno, M. H.4-Oxocyclic Ureas Useful as Antiarrhythmic and Antifibrillatory Agents. U.S. Patent 5,462,940, October 31, 1995."},{"key":"ref55\/cit55","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1994.019.06.253405"},{"key":"ref56\/cit56","doi-asserted-by":"publisher","DOI":"10.1021\/jm00101a017"},{"key":"ref57\/cit57","unstructured":"Fobare, W. F.; Strike, D. P.N,N\u2032,N\u2032-Trisubstituted-5-bisaminomethylene-1,3-dioxane-4,6-dione Inhibitors of Acyl-CoA: Cholesterol-acyl Transferase. U.S. Patent 5,281,714, January 25, 1994."},{"key":"ref58\/cit58","doi-asserted-by":"publisher","DOI":"10.1021\/jm00168a030"},{"key":"ref59\/cit59","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2006.01567.x"},{"key":"ref60\/cit60","doi-asserted-by":"publisher","DOI":"10.1016\/0223-5234(91)90128-A"},{"key":"ref61\/cit61","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(02)00302-8"},{"key":"ref62\/cit62","doi-asserted-by":"publisher","DOI":"10.1021\/jm00054a008"},{"key":"ref63\/cit63","doi-asserted-by":"publisher","DOI":"10.1021\/jm00034a003"},{"key":"ref64\/cit64","unstructured":"Oshiro, Y.; Sato, S.; Kurahashi, N.Carbostyril Derivatives. U.S. Patent 5,006,528, April 9, 1991."},{"key":"ref65\/cit65","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2005.01.005"},{"key":"ref66\/cit66","doi-asserted-by":"publisher","DOI":"10.1021\/ja01577a055"},{"key":"ref67\/cit67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2009.09.027"},{"key":"ref68\/cit68","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199652010-00007"},{"key":"ref69\/cit69","doi-asserted-by":"publisher","DOI":"10.1021\/jm00013a014"},{"key":"ref70\/cit70","unstructured":"Li, J. J.; Johnson, D. S.Modern Drug Synthesis;John Wiley & Sons, Inc.:Hoboken, NJ, 2010; p92."},{"key":"ref71\/cit71","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120030218"},{"key":"ref72\/cit72","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2009.06.042"},{"key":"ref73\/cit73","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.3223"},{"key":"ref74\/cit74","doi-asserted-by":"publisher","DOI":"10.1021\/jm800566m"},{"key":"ref75\/cit75","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.07.011"},{"key":"ref76\/cit76","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.48.21"},{"key":"ref77\/cit77","volume-title":"The War Gases. Chemistry and Analysis","author":"Sartori M.","year":"1939"},{"key":"ref78\/cit78","first-page":"254","volume":"223","author":"Vavon G.","year":"1946","journal-title":"C. R. Hebd. Seances Acad. Sci."},{"key":"ref79\/cit79","unstructured":"Thominet, M. L.Ortho Alkoxy and Alkylthio-polysubstituted-n-tertiaryamino-alkyl Benzamides. U.S. Patent 3,177,252, April 6, 1965."},{"key":"ref80\/cit80","unstructured":"Bloch, L. P.Method for Producing Z-Pyridineal. U.S. Patent 3,123,613, March 3, 1964."},{"key":"ref81\/cit81","unstructured":"Holtermann, H.; Haugen, L. G.; Nordal, V.; Haavaldsen, J. L.Process for the n-Alkylation of Acyl Anilides Halogen Substituted in the Nucleus. U.S. Patent 3,178,473, April 13, 1965."},{"key":"ref82\/cit82","unstructured":"Horstmann, H.; Wollweber, H.; Meng, K.Sulfonamides. British Patent 1,031,916, June 2, 1966."},{"key":"ref83\/cit83","doi-asserted-by":"publisher","DOI":"10.1592\/phco.29.12.1452"},{"key":"ref84\/cit84","doi-asserted-by":"publisher","DOI":"10.1358\/dot.2009.45.9.1399952"},{"key":"ref85\/cit85","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1993.018.11.225970"},{"key":"ref86\/cit86","unstructured":"Satzinger, G.; Herrmann, M.; Fritschi, E.; Hartenstein, J.; Bartoszyk, G.4-Oxothiazolidin-2-ylidene-acetamide Derivatives as CNS Agents. U.S. Patent 4,563,471, January 7, 1986."},{"key":"ref87\/cit87","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(01)00784-X"},{"key":"ref88\/cit88","doi-asserted-by":"crossref","unstructured":"Lednicer, D.Strategies for Organic Drug Synthesis and Design,2nd ed.Wiley-Interscience:Hoboken, NJ, 2008; p233.","DOI":"10.1002\/9780470399613"},{"key":"ref89\/cit89","doi-asserted-by":"publisher","DOI":"10.1021\/op060200g"},{"key":"ref90\/cit90","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000123072.34629.57"},{"key":"ref91\/cit91","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80112-0"},{"key":"ref92\/cit92","doi-asserted-by":"crossref","unstructured":"Li, J. J.; Johnson, D. S.; Sliskovic, D. R.; Roth, B. D.Contemporary Drug Synthesis;John Wiley & Sons, Inc.:Hoboken, NJ, 2004; p14.","DOI":"10.1002\/0471686743"},{"key":"ref93\/cit93","doi-asserted-by":"crossref","unstructured":"Hara, T.Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development;Edward Elgar Publishing, Inc.:Northampton, MA, 2003; p85.","DOI":"10.4337\/9781843765660"},{"key":"ref94\/cit94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2011.02.004"},{"key":"ref95\/cit95","unstructured":"Black, J. W.; Parsons, M. E.Pharmaceutical Compositions and Methods of Inhibiting H-1 and H-2 Histamine Receptors. U.S. Patent 3,894,151, July 8, 1975."},{"key":"ref96\/cit96","unstructured":"Brown, D. M.; Gatter, E. M.; Littau, C. A.Solvent Free Quaternization of Tertiary Amines with Dimethylsulfate. U.S. Patent 5,463,094, October 31, 1995."},{"key":"ref97\/cit97","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1996.tb04758.x"},{"key":"ref98\/cit98","unstructured":"Egri, G.Pharmaceutical Technology;Muegyetemi Publisher:Budapest, 1995; p123."},{"key":"ref99\/cit99","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90384-3"},{"key":"ref100\/cit100","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.05.022"},{"key":"ref101\/cit101","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-2797(00)00206-4"},{"key":"ref102\/cit102","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2009.11.023"},{"key":"ref103\/cit103","doi-asserted-by":"publisher","DOI":"10.1021\/jm00068a006"},{"key":"ref104\/cit104","doi-asserted-by":"publisher","DOI":"10.1021\/jm050101d"},{"key":"ref105\/cit105","doi-asserted-by":"publisher","DOI":"10.1016\/0957-4166(96)00198-X"},{"key":"ref106\/cit106","unstructured":"Yoshiro, F.; Yasushi, M.Process for Preparing Glycidylphthalimide. Eur. Pat. Appl. 1403267, 2004."},{"key":"ref107\/cit107","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363230-00004"},{"key":"ref108\/cit108","unstructured":"Koike, H.; Nishino, H.; Yoshimoto, M.Dihydropyridine Derivatives, Their Preparation and Their Use. U.S. Patent 4,772,596, September 20, 1988."},{"key":"ref109\/cit109","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10792"},{"key":"ref110\/cit110","doi-asserted-by":"publisher","DOI":"10.1016\/0960-894X(95)00426-T"},{"key":"ref111\/cit111","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2010.02.006"},{"key":"ref112\/cit112","unstructured":"Fuji, M.; Suzuki, T.; Hayashibe, S.; Tsukamoto, S.; Yatsugi, S.; Yamaguchi, T.Morpholine Derivative. U.S. Patent 5,521,180, May 28, 1996."},{"key":"ref113\/cit113","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2174\/0929867013373084","volume":"8","author":"Kovacic P.","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"ref114\/cit114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.11.007"},{"key":"ref115\/cit115","doi-asserted-by":"publisher","DOI":"10.1021\/jm0204183"},{"key":"ref116\/cit116","unstructured":"Tang, P. C.; Miller, T.; Li, X.; Sun, L.; Wei, C. C.; Shirazian, S.; Liang, C.; Vojkovsky, T.; Nematalla, A. S.; Hawley, M.Pyrrole Substituted 2-Indolinone Protein Kinase Inhibitors. Int. Patent WO2001060814, August 23, 2001."},{"key":"ref117\/cit117","unstructured":"Lowe, J. A.; Nagel, A. A.Aryl Piperazinyl-(C2 or C4) Alkylene Heterocyclic Compounds Having Neuroleptic Activity. U.S. Patent 4,831,031, May 16, 1989."},{"key":"ref118\/cit118","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2007.00008.x"},{"key":"ref119\/cit119","doi-asserted-by":"publisher","DOI":"10.1021\/ol0474406"},{"key":"ref120\/cit120","doi-asserted-by":"crossref","unstructured":"Enna, S. J.; Bylund, D. B.(Eds).xPharm: The Comprehensive Pharmacology Reference;Elsevier:New York, 2007; pp1\u20137.","DOI":"10.1016\/B978-008055232-3.63305-7"},{"key":"ref121\/cit121","doi-asserted-by":"publisher","DOI":"10.1007\/BF00771896"},{"key":"ref122\/cit122","doi-asserted-by":"publisher","DOI":"10.1021\/jm8011867"},{"key":"ref123\/cit123","doi-asserted-by":"publisher","DOI":"10.1021\/jo00092a026"},{"key":"ref124\/cit124","doi-asserted-by":"publisher","DOI":"10.1021\/jm00380a007"},{"key":"ref125\/cit125","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-081X(199705)18:4<325::AID-BDD21>3.0.CO;2-1"},{"key":"ref126\/cit126","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1992.017.01.161263"},{"key":"ref127\/cit127","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199957060-00015"},{"key":"ref128\/cit128","doi-asserted-by":"publisher","DOI":"10.1016\/0960-894X(96)00323-X"},{"key":"ref129\/cit129","first-page":"3885","volume":"6","author":"Dees E. C.","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref130\/cit130","doi-asserted-by":"publisher","DOI":"10.1021\/jm00403a009"},{"key":"ref131\/cit131","doi-asserted-by":"publisher","DOI":"10.1002\/jhet.5570280261"},{"key":"ref132\/cit132","unstructured":"Smith, B. J. G.; Gudi, R.; Wagner, V. O.; Madraymootoo, W.; Van Velsen, F.; Van Gompel, J.; Bigger, A.,Genetic Toxicity Assessment of the Nitroxide Radical 2,2,6,6-Tetramethylpiperidin-l-oxyl (TEMPO). Presented at Genetic Toxicology Association Meeting, University of Delaware, Newark, DE, September 9\u201310, 2009."},{"key":"ref133\/cit133","doi-asserted-by":"publisher","DOI":"10.1021\/op900059x"},{"key":"ref134\/cit134","volume-title":"Process Chemistry in the Pharmaceutical Industry. Volume 2: Challenges in an Ever Changing Climate","author":"Borghese A.","year":"2007"},{"key":"ref135\/cit135","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200600031"},{"key":"ref136\/cit136","doi-asserted-by":"publisher","DOI":"10.1055\/s-2005-865208"},{"key":"ref137\/cit137","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetlet.2005.05.082"},{"key":"ref138\/cit138","unstructured":"Wood, A.; Perros, M.; Price, D. A.; Stammen, B. L. C.Tryasolyl Tropane Derivatives as Ccr5Modulators. Int. Patent WO2001090106, November 29, 2001."},{"key":"ref139\/cit139","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200600103"},{"key":"ref140\/cit140","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4039(98)02633-1"},{"key":"ref141\/cit141","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2010.10.003"},{"key":"ref142\/cit142","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2011.07.010"},{"key":"ref143\/cit143","doi-asserted-by":"publisher","DOI":"10.1021\/jo801830x"},{"key":"ref144\/cit144","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2009.06.022"},{"key":"ref145\/cit145","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2006.07.015"},{"key":"ref146\/cit146","doi-asserted-by":"publisher","DOI":"10.1021\/op100266s"},{"key":"ref147\/cit147","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2009.10.005"},{"key":"ref148\/cit148","doi-asserted-by":"publisher","DOI":"10.1126\/science.1153813"},{"key":"ref149\/cit149","doi-asserted-by":"publisher","DOI":"10.1021\/op100157q"},{"key":"ref150\/cit150","doi-asserted-by":"publisher","DOI":"10.1021\/op9002505"},{"key":"ref151\/cit151","doi-asserted-by":"publisher","DOI":"10.1021\/op100118e"},{"key":"ref152\/cit152","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2012.07.006"},{"key":"ref153\/cit153","doi-asserted-by":"publisher","DOI":"10.2174\/157018007781788561"},{"key":"ref154\/cit154","first-page":"589","volume":"3","author":"Venkateswara Rao B.","year":"2011","journal-title":"J. Chem. Pharm. Res."},{"key":"ref155\/cit155","unstructured":"Stamvik, A. R.; Kristensson, S. K.; Lundvall, K.Steroid Esters Preparation. U.S. Patent 4,537,722, August 27, 1985."},{"key":"ref156\/cit156","doi-asserted-by":"publisher","DOI":"10.1021\/jo800264d"},{"key":"ref157\/cit157","doi-asserted-by":"publisher","DOI":"10.1021\/ja0616433"},{"key":"ref158\/cit158","doi-asserted-by":"publisher","DOI":"10.1021\/ol034217k"},{"key":"ref159\/cit159","unstructured":"Sallmann, A.; Pfister, R.Substituted Derivatives of 2-Anilinophenylacetic Acids and a Process of Preparation. U.S. Patent 3,558,690, January 26, 1971."},{"key":"ref160\/cit160","unstructured":"Vanhoenacker, G.; David, F.; Sandra, P.Agilent Technologies,Publication Number 5990-5732EN, 2010."},{"key":"ref161\/cit161","doi-asserted-by":"publisher","DOI":"10.1021\/cc034014n"},{"key":"ref162\/cit162","unstructured":"Chlorhexidine facts.http:\/\/www.chlorhexidinefacts.com\/history-of-chlorhexidine.html, accessed on July 11, 2013."},{"key":"ref163\/cit163","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrgentox.2011.05.006"},{"key":"ref164\/cit164","doi-asserted-by":"crossref","unstructured":"Hall, D. G.(Ed.)Boronic Acids: Preparation and Applications in Organic Synthesis and Medicine;Wiley-VCH Verlag GmbH:Weinheim, Germany, 2005; pp1\u20132.","DOI":"10.1002\/3527606548"},{"key":"ref165\/cit165","doi-asserted-by":"publisher","DOI":"10.1039\/b311103b"},{"key":"ref166\/cit166","doi-asserted-by":"publisher","DOI":"10.1080\/00397918108063618"},{"key":"ref167\/cit167","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2007.01.020"},{"key":"ref168\/cit168","doi-asserted-by":"publisher","DOI":"10.1055\/s-0031-1299988"},{"key":"ref169\/cit169","doi-asserted-by":"crossref","unstructured":"Hall, D. G.(Ed.)Boronic Acids: Preparation and Applications in Organic Synthesis and Medicine;Wiley-VCH Verlag GmbH:Weinheim, Germany, 2005; pp17\u201318.","DOI":"10.1002\/3527606548"},{"key":"ref170\/cit170","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(97)82002-5"},{"key":"ref171\/cit171","doi-asserted-by":"publisher","DOI":"10.1021\/jo9824910"},{"key":"ref172\/cit172","doi-asserted-by":"publisher","DOI":"10.1021\/jo00100a048"},{"key":"ref173\/cit173","doi-asserted-by":"publisher","DOI":"10.1021\/op300216x"},{"key":"ref174\/cit174","first-page":"27","volume":"12","author":"European Directorate for Quality of Medicines and Healthcare.","year":"2000","journal-title":"PharmEuropa"},{"key":"ref175\/cit175","volume-title":"Mesylate Ester Type Impurities Contained in Medicinal Products","year":"2007"},{"key":"ref176\/cit176","volume-title":"Request To Assess the Risk of Occurrence of Contamination with Mesilate Esters and Other Related Compounds in Pharmaceuticals","author":"Hoog T. J.-d.","year":"2008"},{"issue":"4","key":"ref177\/cit177","first-page":"691","volume":"23","year":"2011","journal-title":"PharmEuropa"},{"key":"ref178\/cit178","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2009.03.016"},{"key":"ref179\/cit179","doi-asserted-by":"publisher","DOI":"10.1021\/op800192a"},{"key":"ref180\/cit180","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.61.03.0001"},{"key":"ref181\/cit181","unstructured":"Dressman, B. A.; Fritz, J. E.; Hammond, M.; Hornback, W. J.; Kaldor, S. W.; Kalish, V. J.; Munroe, J. E.; Reich, S. H.; Tatlock, J. H.; Shepherd, T. A.;HIV Protease Inhibitors. U.S. Patent 5,484,926, January 16, 1996."},{"key":"ref182\/cit182","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/0-306-47384-4_13","volume":"11","author":"Adams W. J.","year":"1998","journal-title":"Pharm. Biotechnol."},{"key":"ref183\/cit183","unstructured":"Copp, F. C.; Stephenson, D.Quaternary Ammonium Compounds. U.S. Patent 3,038,004, June 5, 1962."},{"key":"ref184\/cit184","doi-asserted-by":"publisher","DOI":"10.1021\/op900178d"},{"key":"ref185\/cit185","doi-asserted-by":"publisher","DOI":"10.1021\/op900301n"},{"key":"ref186\/cit186","doi-asserted-by":"publisher","DOI":"10.1002\/jps.22058"},{"key":"ref187\/cit187","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1086-1093.2001"},{"key":"ref188\/cit188","volume-title":"CHMP Assessment Report for Viracept","author":"European Medicines Agency","year":"2007"},{"key":"ref189\/cit189","doi-asserted-by":"publisher","DOI":"10.1186\/1742-6405-6-18"},{"key":"ref190\/cit190","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2009.02.020"},{"key":"ref191\/cit191","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(99)00002-2"},{"key":"ref192\/cit192","volume-title":"Dictionary of Pharmacological Agents","author":"Ganellin C. R","year":"1997"},{"key":"ref193\/cit193","unstructured":"Huebner, C. F.N-Oxacyclic-Alkylpiperidines as Psychostimulants. U.S. Patent 4,329,348, May 11, 1982."},{"key":"ref194\/cit194","unstructured":"Rubio, Z. P.; Cirera, D. X.; Irurre, P. J.;Bis-Tri:fluoro-ethoxy piperidinyl-methyl Benzamide Acetate Prepn. Patent ES2007802, July 1, 1989."},{"key":"ref195\/cit195","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90601-6"},{"key":"ref196\/cit196","doi-asserted-by":"publisher","DOI":"10.1021\/jm9509556"},{"key":"ref197\/cit197","unstructured":"Lednicer, D.The Organic Chemistry of Drug Synthesis;John Wiley and Sons Inc.:Hoboken, NJ, 1999; p40."},{"key":"ref198\/cit198","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02003.x"},{"key":"ref199\/cit199","unstructured":"Elks, J.; Phillipps, G. H.Halopregnenones. Ger. Offen. DE 1902340, 1969."},{"key":"ref200\/cit200","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.43"},{"key":"ref201\/cit201","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2310\/6620.2010.10036","volume":"21","author":"Nedorost S. T.","year":"2010","journal-title":"Dermatitis"},{"key":"ref202\/cit202","unstructured":"Torossian, D. R.; Aubard, G. G.; Legeai, J. M. G.Esters of 21-Thiol Steroids. U.S. Patent 4,014,909, March 29, 1977."},{"key":"ref203\/cit203","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1991.016.06.140159"},{"key":"ref204\/cit204","first-page":"1","volume":"21","author":"Suschitzky J. L.","year":"1984","journal-title":"Prog. Med. Chem."},{"key":"ref205\/cit205","unstructured":"Spicer, J. W.; Warren, B. T.1-(4-Cyano-phenoxy)-2-hydroxy-3-[2-(5-1H-tetrazolyl)-chromon-5-yloxy]-propane and Salts Thereof. U.S. Patent 4,238,495, December 9, 1980."},{"key":"ref206\/cit206","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm179"},{"key":"ref207\/cit207","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1982.007.04.199368"},{"key":"ref208\/cit208","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0090-9556(24)15172-0","volume":"28","author":"Dockens R.","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"ref209\/cit209","doi-asserted-by":"publisher","DOI":"10.1358\/dof.1994.019.02.236186"},{"key":"ref210\/cit210","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(01)80353-X"},{"key":"ref211\/cit211","doi-asserted-by":"publisher","DOI":"10.1021\/jo00092a026"},{"key":"ref212\/cit212","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)01422-X"},{"key":"ref213\/cit213","doi-asserted-by":"publisher","DOI":"10.1021\/jo00079a022"},{"key":"ref214\/cit214","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2003.tb00248.x"},{"key":"ref215\/cit215","unstructured":"Kaplan, J. L.; McMillan, M. W.Analgesic 2-Oxa-spirocyclic Compounds. U.S. Patent 4,588,591, May 13, 1986."},{"key":"ref216\/cit216","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(09)70199-9"},{"key":"ref217\/cit217","doi-asserted-by":"publisher","DOI":"10.1021\/jm980162u"},{"key":"ref218\/cit218","doi-asserted-by":"publisher","DOI":"10.1021\/op7001134"},{"key":"ref219\/cit219","doi-asserted-by":"publisher","DOI":"10.1021\/jm00166a011"},{"key":"ref220\/cit220","unstructured":"Parthasaradhi, B.; Rathnakar, K.; Raji, R.; Muralidhara, D.Process for Substituted Sulfoxides. U.S. Patent 7,176,319, February 13, 2007."},{"key":"ref221\/cit221","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262100-00006"},{"key":"ref222\/cit222","doi-asserted-by":"publisher","DOI":"10.1021\/jm00105a050"},{"key":"ref223\/cit223","doi-asserted-by":"crossref","unstructured":"Greene, T. W.; Wuts, P. G. M.Protective Groups in Organic Synthesis,3rd ed.John Wiley & Sons, Inc.:Hoboken, NJ, 1999; p49.","DOI":"10.1002\/0471220574"},{"key":"ref224\/cit224","unstructured":"Egri, G.Pharmaceutical Technology;Muegyetemi Publisher:Budapest, 1995; p160."},{"key":"ref225\/cit225","unstructured":"Johnson, D. S.; Li, J. J.The Art of Drug Synthesis;John Wiley & Sons, Inc.:Hoboken, NJ, 2007; pp17\u201318."},{"key":"ref226\/cit226","doi-asserted-by":"publisher","DOI":"10.1016\/S0957-4166(98)00291-2"},{"key":"ref227\/cit227","doi-asserted-by":"publisher","DOI":"10.2533\/000942904777677605"},{"key":"ref228\/cit228","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060068"},{"key":"ref229\/cit229","doi-asserted-by":"publisher","DOI":"10.1021\/jo9609539"},{"key":"ref230\/cit230","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(97)00006-8"},{"key":"ref231\/cit231","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh029"},{"key":"ref232\/cit232","unstructured":"Stuk, T. L.; Allen, M. S.; Haight, A. R.; Kerdesky, F. A.; Langridge, D. C.; Leanna, R. M.; Lijewski, L. M.; Melcher, L.; Morton, H. E.; Norbeck, D. W.;Process for the Preparation of a Substituted 2,5-Diamino-3-hydroxyhexane. U.S. Patent 5,491,253, February 13, 1996."},{"key":"ref233\/cit233","unstructured":"Kronenthal, D.; Kuester, P. L.; Mueller, R. H.Process for Preparing (trans)-4-Phenyl-L-proline Derivatives. U.S. Patent 4,912,231, March 27, 1990."},{"key":"ref234\/cit234","unstructured":"Stimac, A.; Mohar, B.; Stephan, M.; Bevc, M.; Zupet, R.; Gartner, A.; Kroselj, V.; Smrkolj, M.; Kidemet, D.; Sedmak, G.;Process for the Preparation of Ezetimibe and Derivatives Thereof. Int. Patent WO2008089984, September 18, 2008."},{"key":"ref235\/cit235","doi-asserted-by":"publisher","DOI":"10.1021\/op0498013"},{"key":"ref236\/cit236","doi-asserted-by":"publisher","DOI":"10.1016\/S0040-4020(99)00809-1"},{"key":"ref237\/cit237","unstructured":"Yasuda, Y.Method of Producing Polysaccharide Derivatives. Int. Patent WO2007126154, November 8, 2007."},{"key":"ref238\/cit238","doi-asserted-by":"publisher","DOI":"10.1039\/b801090k"},{"key":"ref239\/cit239","doi-asserted-by":"publisher","DOI":"10.1021\/jo7014906"},{"key":"ref240\/cit240","doi-asserted-by":"publisher","DOI":"10.1021\/ol006779z"},{"key":"ref241\/cit241","doi-asserted-by":"publisher","DOI":"10.1021\/jo034785d"},{"key":"ref242\/cit242","doi-asserted-by":"publisher","DOI":"10.1021\/jo101776y"},{"key":"ref243\/cit243","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2009.07.002"},{"key":"ref244\/cit244","unstructured":"Erhart, G.; Lindner, E.; Ott, H.Basically Substituted Diphenyl-methane Derivatives and Process for Preparing Them. Ger. Offen. DE1111642, July 27, 1961."},{"key":"ref245\/cit245","unstructured":"Reynolds, J. E. F.; Parfitt, K.Martindale: The Extra Pharmacopoeia,30th ed.Pharmaceutical Press:London, 1989; p1406."},{"key":"ref246\/cit246","unstructured":"ClinicalTrial.gov.Placebo Controlled Study in Subjects with Relapsing Forms of MS To Evaluate the Safety, Tolerability and Effects of CDP323.http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00484536?term=CDP323&rank=1, accessed Aug 09, 2011."},{"key":"ref247\/cit247","doi-asserted-by":"publisher","DOI":"10.1021\/op900330e"},{"key":"ref248\/cit248","doi-asserted-by":"publisher","DOI":"10.1021\/op8002294"},{"key":"ref249\/cit249","unstructured":"Johnson, D. S.; Li, J. J.The Art of Drug Synthesis;John Wiley & Sons, Inc.:Hoboken, NJ, 2007; p108."},{"key":"ref250\/cit250","unstructured":"Drugs.com.Armodafinil.http:\/\/www.drugs.com\/monograph\/armodafinil.html, accessed on Aug 9, 2011."},{"key":"ref251\/cit251","unstructured":"Kaspi, J.; Leman, O.; Lexner, J.; Menashe, N.; Naddaka, V.; Saeed, S.Process for the Preparation of Diphenylmethylthioacetamide. European Patent EP1260501, November 27, 2002."},{"key":"ref252\/cit252","unstructured":"Frey, E.; Slater, C. S.; Savelski, M. J.; Hesketh, R. P.The Selection and Reduction of Organic Solvents in Pharmaceutical Manufacture. Presented at the American Chemical Society 10th Green Chemistry and Engineering Conference, Washington 2006."},{"key":"ref253\/cit253","unstructured":"European Medicines Agency. ICH Q3C Guideline, Impurities: Residual Solvents. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2011\/03\/WC500104258.pdf."},{"key":"ref254\/cit254","volume-title":"Guidance to Industry: Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients","year":"2001"},{"key":"ref255\/cit255","volume-title":"Handbook of Chemistry and Physics","author":"Lide D. R.","year":"2008","edition":"88"},{"key":"ref256\/cit256","doi-asserted-by":"publisher","DOI":"10.1080\/00984100050166343"},{"key":"ref257\/cit257","doi-asserted-by":"publisher","DOI":"10.1080\/00039890009603417"},{"key":"ref258\/cit258","volume-title":"Hazard Assessment Report: N,N-Dimethylformamide","year":"2007"},{"key":"ref259\/cit259","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2280(1998)31:4<301::AID-EM1>3.0.CO;2-L"},{"key":"ref260\/cit260","unstructured":"Hazard Assessment Report: N,N-Dimethylformamide;Chemicals Evaluation and Research Institute (CERI\/Japan):Tokyo, May 2007; p6."},{"key":"ref261\/cit261","volume-title":"Integrated Risk Information System (IRIS) on 1,4-Dioxane","year":"1999"},{"key":"ref262\/cit262","volume-title":"Toxicological Profile for Methylene Chloride","author":"Koplan J. P.","year":"2000"},{"key":"ref263\/cit263","unstructured":"Horstmann, H.; Wollweber, H.; Meng, K.Mefruside. British Patent 1,031,916, June 2, 1967."},{"key":"ref264\/cit264","volume-title":"Guidance for Industry, Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches","author":"Jacobson-Kram D.","year":"2008"},{"key":"ref265\/cit265","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2010.11.039"},{"key":"ref266\/cit266","doi-asserted-by":"publisher","DOI":"10.1021\/op900242x"},{"key":"ref267\/cit267","doi-asserted-by":"publisher","DOI":"10.1021\/op700248t"},{"key":"ref268\/cit268","doi-asserted-by":"publisher","DOI":"10.1021\/cr050982w"},{"key":"ref269\/cit269","doi-asserted-by":"publisher","DOI":"10.1021\/op700226s"},{"key":"ref270\/cit270","doi-asserted-by":"publisher","DOI":"10.1021\/op100141g"},{"key":"ref271\/cit271","doi-asserted-by":"publisher","DOI":"10.1021\/op900018f"},{"key":"ref272\/cit272","doi-asserted-by":"publisher","DOI":"10.1021\/op050122h"},{"key":"ref273\/cit273","doi-asserted-by":"publisher","DOI":"10.1021\/op900338g"},{"key":"ref274\/cit274","unstructured":"Teasdale, A.; Covey-Crump, L.2013 Virtual ICGM3: Introduction to the GTI Purge Tool Project;http:\/\/www.lhasalimited.org\/Default.aspx.LocID-03k00k004.Lang-EN.emID-1239.cal-yes.EventID-20397.htm, last accessed March 21, 2015."},{"key":"ref275\/cit275","doi-asserted-by":"publisher","DOI":"10.1021\/op034047r"},{"key":"ref276\/cit276","volume-title":"Handbook of Optical Resolution via Diastereomeric Crystallisation","author":"Kozma D.","year":"2002"},{"key":"ref277\/cit277","doi-asserted-by":"publisher","DOI":"10.1016\/j.tetasy.2006.04.036"},{"key":"ref278\/cit278","doi-asserted-by":"publisher","DOI":"10.1021\/op050049v"},{"key":"ref279\/cit279","doi-asserted-by":"publisher","DOI":"10.1021\/acs.iecr.5b00693"},{"key":"ref280\/cit280","doi-asserted-by":"publisher","DOI":"10.1016\/j.ces.2013.11.008"},{"key":"ref281\/cit281","doi-asserted-by":"publisher","DOI":"10.1016\/j.cherd.2009.09.006"},{"key":"ref282\/cit282","doi-asserted-by":"publisher","DOI":"10.1021\/op0600456"},{"key":"ref283\/cit283","doi-asserted-by":"publisher","DOI":"10.1016\/j.compchemeng.2010.03.019"},{"key":"ref284\/cit284","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.34542"},{"key":"ref285\/cit285","first-page":"66","volume":"3","author":"Prabu S. L.","year":"2010","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"ref286\/cit286","doi-asserted-by":"publisher","DOI":"10.1208\/pt030206"},{"key":"ref287\/cit287","doi-asserted-by":"publisher","DOI":"10.1021\/op1000397"},{"key":"ref288\/cit288","doi-asserted-by":"publisher","DOI":"10.1016\/j.cherd.2008.12.016"},{"key":"ref289\/cit289","doi-asserted-by":"publisher","DOI":"10.1021\/op049764f"},{"key":"ref290\/cit290","doi-asserted-by":"publisher","DOI":"10.1002\/1615-9314(20020901)25:13<847::AID-JSSC847>3.0.CO;2-2"},{"key":"ref291\/cit291","doi-asserted-by":"publisher","DOI":"10.1006\/jcis.1999.6176"},{"key":"ref292\/cit292","doi-asserted-by":"publisher","DOI":"10.1081\/JLC-120021763"},{"key":"ref293\/cit293","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2012.09.028"},{"key":"ref294\/cit294","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(96)00903-X"},{"key":"ref295\/cit295","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(98)00246-1"},{"key":"ref296\/cit296","doi-asserted-by":"publisher","DOI":"10.1021\/op9000093"},{"key":"ref297\/cit297","doi-asserted-by":"publisher","DOI":"10.1021\/jo00408a041"},{"key":"ref298\/cit298","doi-asserted-by":"publisher","DOI":"10.1021\/ar010070q"},{"key":"ref299\/cit299","doi-asserted-by":"publisher","DOI":"10.1021\/js9700661"},{"key":"ref300\/cit300","doi-asserted-by":"publisher","DOI":"10.1002\/jssc.200700579"},{"key":"ref301\/cit301","doi-asserted-by":"publisher","DOI":"10.1021\/cr500006j"},{"key":"ref302\/cit302","doi-asserted-by":"publisher","DOI":"10.1080\/01496390701477063"},{"key":"ref303\/cit303","doi-asserted-by":"publisher","DOI":"10.1039\/C2GC36239B"},{"key":"ref304\/cit304","doi-asserted-by":"publisher","DOI":"10.1039\/C3GC41402G"},{"key":"ref305\/cit305","doi-asserted-by":"publisher","DOI":"10.1016\/j.memsci.2011.07.007"},{"key":"ref306\/cit306","doi-asserted-by":"publisher","DOI":"10.1021\/sc5004083"},{"key":"ref307\/cit307","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-7799(00)01523-7"},{"key":"ref308\/cit308","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-9936(98)00092-2"},{"key":"ref309\/cit309","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1352(199634\/12)9:5\/6<691::AID-JMR322>3.0.CO;2-G"},{"key":"ref310\/cit310","doi-asserted-by":"publisher","DOI":"10.1021\/ja00024a046"},{"key":"ref311\/cit311","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.5b00755"},{"key":"ref312\/cit312","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2011.11.004"},{"key":"ref313\/cit313","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2012.03.092"},{"key":"ref314\/cit314","doi-asserted-by":"publisher","DOI":"10.1016\/j.seppur.2011.10.023"},{"key":"ref315\/cit315","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2014.03.008"},{"key":"ref316\/cit316","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2014.02.073"}],"container-title":["Chemical Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/cr300095f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T22:47:28Z","timestamp":1748558848000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/cr300095f"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,7]]},"references-count":316,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2015,8,26]]}},"alternative-id":["10.1021\/cr300095f"],"URL":"https:\/\/doi.org\/10.1021\/cr300095f","relation":{},"ISSN":["0009-2665","1520-6890"],"issn-type":[{"value":"0009-2665","type":"print"},{"value":"1520-6890","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,7]]}}}